As phar­mas dou­ble down on dig­i­tal and AI, tal­ent is a key con­sid­er­a­tion, con­sul­tant says

“Dig­i­tal,” “dig­i­tal-first” and “dig­i­ti­za­tion” have been buzz­words in phar­ma mar­ket­ing and com­mer­cial strat­e­gy for more than a decade. But the typ­i­cal way that hap­pened was by dig­i­tiz­ing ex­ist­ing ecosys­tems.

Now, with the re­al-world adop­tion of ar­ti­fi­cial in­tel­li­gence, “the en­tire busi­ness con­struct is get­ting reimag­ined,” said ZS man­ag­ing part­ner Mah­mood Ma­jeed.

That means shift­ing or cre­at­ing new busi­ness mod­els, but al­so chang­ing up the tal­ent pool. Phar­mas need to think about new kinds of tal­ent fun­da­men­tals such as ex­per­tise in dig­i­tal da­ta and AI, and more gen­er­al­ly the abil­i­ty to work dif­fer­ent­ly, said Ma­jeed, who leads the man­age­ment con­sul­tan­cy’s dig­i­tal and tech­nol­o­gy busi­ness.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER